S S Hayreh. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » FibrinolysisFibrinolytic Agents/therapeutic useHumansRecombinant Proteins/therapeutic useRetinal Artery Occlusion/drug therapyThrombolytic Therapy/methodsTissue Plasminogen Activator/therapeutic useVisual Acuity
Substances: See more » Fibrinolytic AgentsRecombinant ProteinsTissue Plasminogen Activator
Year: 1999 PMID: 10406599 DOI: 10.1016/S0161-6420(99)10101-5
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079